In highly invasive CD44 expressing breast carcinomas, tumor cells also express a hyaluronic acid binding protein that activates matrix metalloproteases (MMP) 2 and 9 on cell membranes [23,24]. The gene discussed is CD44; the disease is breast carcinoma.